Longitudinal Data Analysis: Autoregressive Linear Mixed Effects Models

Funatogawa, Ikuko/ Funatogawa, Takashi

ISBN 10: 981100076X / ISBN 13: 9789811000768

Editore: Springer Verlag, 2019

Riguardo questo articolo

152 pages. 9.25x6.25x0.50 inches. In Stock.

Codice articolo zk981100076X

Dati bibliografici

• Titolo: Longitudinal Data Analysis: Autoregressive Linear Mixed Effects Models
• Editore: Springer Verlag
• Data di pubblicazione: 2019
• Lingua: Inglese
• ISBN 10: 981100076X
• ISBN 13: 9789811000768
• Rilegatura: Paperback
• Condizione: Brand New

Descrizione articolo

Riassunto

This book provides a new analytical approach for dynamic data repeatedly measured from multiple subjects over time. Random effects account for differences across subjects. Auto-regression in response itself is often used in time series analysis. In longitudinal data analysis, a static mixed effects model is changed into a dynamic one by the introduction of the auto-regression term. Response levels in this model gradually move toward an asymptote or equilibrium which depends on covariates and random effects. The book provides relationships of the autoregressive linear mixed effects models with linear mixed effects models, marginal models, transition models, nonlinear mixed effects models, growth curves, differential equations, and state space representation. State space representation with a modified Kalman filter provides log likelihoods for maximum likelihood estimation, and this representation is suitable for unequally spaced longitudinal data. The extension to multivariate longitudinal data analysis is also provided. Topics in medical fields, such as response-dependent dose modifications, response-dependent dropouts, and randomized controlled trials are discussed. The text is written in plain terms understandable for researchers in other disciplines such as econometrics, sociology, and ecology for the progress of interdisciplinary research.

Informazioni sull?autore

Ikuko Funatogawa, The Institute of Statistical Mathematics

Takashi Funatogawa, Chugai Pharmaceutical Co. Ltd.